Company Overview
Snapshot
Founded in August 2010 by Yoram Romem and Amos Shattner, HealthWatch operated with 1–10 employees. The company secured $20 million across one funding round from Yiling Pharmaceutical. A significant milestone for HealthWatch was winning the Most Promising Start-Up for 2018 award at the China-Israel Summit in November 2017.
Business overview
HealthWatch specializes in smart digital textile garments designed for personal health monitoring. The company's core technology provides high-quality continuous ECGs (3-15 lead), vital sign tracking, and alerts for telemedicine applications via smartphones and standard telemetry systems. Its garments, including the MasterCaution platform, are utilized for Holter monitoring, event-loop recording, exercise stress testing, telehealth, and telecardiology, serving the Health Tech & Life Sciences sector with a focus on medical devices and digital healthcare.
Strategic signal
In November 2017, HealthWatch Technologies was recognized as the Most Promising Start-Up for 2018 by the China-Israel Summit. This award highlighted the company's innovative approach to integrating medical monitoring into wearable technology, signaling strong potential for market adoption and strategic partnerships within the health tech industry at the time.
Company Intelligence Q&A
- What is HealthWatch's primary offering?
- HealthWatch offers smart digital textile garments equipped with sensors for continuous monitoring of vital signs, including high-quality ECGs, for personal health applications and telemedicine.
- When was HealthWatch founded and by whom?
- HealthWatch was founded in August 2010 by Yoram Romem and Amos Shattner.
- What significant award did HealthWatch receive?
- In November 2017, HealthWatch Technologies won the Most Promising Start-Up for 2018 award at the China-Israel Summit.
- What is the status of HealthWatch?
- HealthWatch is currently non-active, having ceased operations in September 2024.
- What is the total disclosed funding raised by HealthWatch?
- HealthWatch raised a total of $20 million in a funding round in December 2016 from Yiling Pharmaceutical.